Novel polynucleotides related to oligonucleotide arrays to monitor gene expression

• US 20060003958A1
• Filed: 05/11/2005
• Published: 01/05/2006
• Est. Priority Date: 05/11/2004
• Status: Abandoned Application

• Current Assignee: Wyeth (Pfizer Inc.)
• Original Assignee: Wyeth (Pfizer Inc.)
• Inventors: Sinacore, Martin S., Lee, Gene W., Brown, Eugene L., Miller, Christopher P., Charlebois, Timothy S., Melville, Mark W., Mounts, William M., Hann, Louane E., Leonard, Mark W.
• Application Number:
  US11/128,061
• Publication Number:
  US 20060003958A1
• Time in Patent Office: Days
• US Class Current: 514/44.A
• CPC Class Codes: C07K 14/47 from mammals
• CPC Class Codes: C12Q 1/6837 using probe arrays or probe chips C12Q1/6874 takes precedence
• CPC Class Codes: C12Q 1/6876 Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
• CPC Class Codes: C12Q 2600/158 Expression markers

Abstract

The present invention provides an oligonucleotide array capable of identifying genes and related pathways involved with the induction of a particular phenotype by a cell line, e.g., the genes and related pathways involved with the induction of transgene expression by the cell line. The invention is particularly useful when there is little or no information about the genome of the cell line being studied, because it provides methods for identifying consensus sequences for known and previously undiscovered genes, and for designing oligonucleotide probes to the identified consensus sequences. Additionally, when the array is to be used to determine optimal conditions for expression of a transgene by the cell line, the invention teaches methods of including oligonucleotide probes to transgene sequences in the array. The invention also provides methods of using the array to identify genes and related pathways involved with the induction of a particular cell line phenotype. The invention also provides novel polynucleotides of undiscovered genes (i.e., a gene that had not been sequenced and/or shown to be expressed by CHO cells) and novel polynucleotides involved with the induction of a particular cell phenotype, e.g., increased survival when grown under stressful culture conditions, increased transgene expression, decreased production of an antigen, etc. These novel polynucleotides are termed novel CHO sequences and differential CHO sequences, respectively. The invention also provides genetically engineered expression vectors, host cells, and transgenic animals comprising the novel nucleic acid molecules of the invention. The invention additionally provides antisense and RNAi molecules to the nucleic acid molecules of the invention. The invention further provides methods of using the polynucleotides of the invention.

Claims

1. An isolated nucleic acid molecule having a polynucleotide sequence selected from the group consisting of the polynucleotide sequences of SEQ ID NOs:

3421-3574, complements thereof, and subsequences thereof.

2. The isolated nucleic acid molecule as in claim 1, wherein said nucleic acid molecule is operably linked to at least one expression control sequence.

3. A host cell transformed or transfected with the nucleic acid molecule of claim 2.

4. An isolated nucleic acid molecule that specifically hybridizes under highly stringent conditions to the polynucleotide sequence of claim 1.

5. An antisense oligonucleotide complementary to an mRNA corresponding to the isolated nucleic acid molecule of claim 1.

6. An isolated gene having the isolated nucleic acid molecule of claim 1.

7. An isolated allele of the isolated nucleic acid molecule of claim 1.

8. A nonhuman transgenic animal in which all of the somatic and germ cells contain DNA having the isolated nucleic acid molecule of claim 1.

9. An siRNA molecule for inhibiting expression of a gene having, the polynucleotide sequence of claim 1.

10. A method of increasing transgene expression by a cell population comprising targeting the cell population with an inhibitory polynucleotide.

11. The method of claim 10, wherein the inhibitory polynucleotide is an antisense oligonucleotide as in claim 5.

12. The method of claim 11, wherein the cell population is a population of CHO cells.

13. The method of claim 10, wherein the inhibitory polynucleotide is an siRNA molecule as in claim 9.

14. The method of claim 13, wherein the cell population is a population of CHO cells.

15. A method of identifying a compound capable of increasing survival of a cell population grown under stressful conditions, increasing transgene expression by a cell population, or decreasing the production of an antigen comprising the steps of:

(a) contacting a first cell population expressing a gene having a polynucleotide sequence selected from the group consisting of the polynucleotide sequences of SEQ ID NOs;

3421-3572, complements thereof, and subsequences thereof with one of a plurality of test compounds; and

(b) comparing the expression of the gene having a polynucleotide sequence selected from the group consisting of the polynucleotide sequences of SEQ ID NOs;

3421-3572, complements thereof, and subsequences thereof in the first population of cells with the expression of the gene in a second population of cells not contacted with the test compound, wherein a decrease in the expression of the gene having a polynucleotide sequence selected from the group consisting of the polynucleotide sequences of SEQ ID NOs;

3421-3572, complements thereof, and subsequences thereof in the first sample, as compared with that in the second sample, identifies the compound as capable of increasing transgene expression.

16. The method of claim 15, wherein the step of comparing is performed with an oligonucleotide array comprising a plurality of oligonucleotide probes, wherein the plurality of oligonucleotide probes comprises a first set of oligonucleotide probes, wherein each oligonucleotide probe in the first set of oligonucleotide probes is specific for one of a plurality of template sequences, wherein the plurality of template sequences comprises at least one consensus sequence for a gene expressed by a cell derived from hamster, and wherein at least one oligonucleotide probe is specific for the at least one consensus sequence for a gene expressed by hamster.

17. A novel CHO polynucleotide having a polynucleotide sequence selected from the group consisting of the polynucleotide sequences of SEQ ID NOs:

19-3573, wherein the polynucleotide sequence was previously undiscovered.

18. A differential CHO polynucleotide having a polynucleotide sequence selected from the group consisting of the polynucleotide sequences of SEQ ID NOs:

19-3574, wherein expression of the differential CHO polynucleotide is correlated with increased survival of a cell grown under stressful culture conditions, increased transgene expression, or decreased production of an antigen.

19. The differential CHO polynucleotide of claim 18, wherein the polynucleotide sequence was previously undiscovered.